HAZEN SAMUEL N (CIK 1216838) reported 20 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-12). Recent activity: Buy HCA (54,934 shares), Sell HCA (21,323 shares), Sell HCA (14,716 shares), Sell HCA (5,002 shares), Sell HCA (7,395 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-12 | HCA Healthcare, Inc. (HCA) | CEO | Buy | 54,934 | $0 |
| 2026-02-12 | HCA Healthcare, Inc. (HCA) | CEO | Sell | 21,323 | $10.7M |
| 2026-02-05 | HCA Healthcare, Inc. (HCA) | CEO | Sell | 14,716 | $7.4M |
| 2026-02-05 | HCA Healthcare, Inc. (HCA) | CEO | Sell | 5,002 | $2.5M |
| 2026-02-05 | HCA Healthcare, Inc. (HCA) | CEO | Sell | 7,395 | $3.7M |
| 2026-02-05 | HCA Healthcare, Inc. (HCA) | CEO | Sell | 6,189 | $3.1M |
| 2026-02-05 | HCA Healthcare, Inc. (HCA) | CEO | Sell | 5,162 | $2.6M |
| 2026-02-05 | HCA Healthcare, Inc. (HCA) | CEO | Sell | 4,293 | $2.1M |
| 2026-02-05 | HCA Healthcare, Inc. (HCA) | CEO | Sell | 120 | $59,662 |
| 2026-02-05 | HCA Healthcare, Inc. (HCA) | CEO | Sell | 1,045 | $520,776 |
| 2026-02-05 | HCA Healthcare, Inc. (HCA) | CEO | Buy | 1,045 | $520,776 |
| 2026-02-02 | HCA Healthcare, Inc. (HCA) | CEO | Buy | 84,360 | $6.9M |
| 2026-02-02 | HCA Healthcare, Inc. (HCA) | CEO | Sell | 41,483 | $20.3M |
| 2025-11-18 | HCA Healthcare, Inc. (HCA) | CEO | Sell | 14,830 | $0 |
| 2025-11-04 | HCA Healthcare, Inc. (HCA) | CEO | Buy | 58,050 | $4.0M |
| 2025-11-04 | HCA Healthcare, Inc. (HCA) | CEO | Sell | 28,173 | $13.0M |
| 2025-05-15 | HCA Healthcare, Inc. (HCA) | CEO | Sell | 90,076 | $0 |
| 2025-05-15 | HCA Healthcare, Inc. (HCA) | CEO | Buy | 90,076 | $0 |
| 2025-02-18 | HCA Healthcare, Inc. (HCA) | CEO | Buy | 13,218 | $0 |
| 2025-02-18 | HCA Healthcare, Inc. (HCA) | CEO | Sell | 4,742 | $1.5M |
Source: SEC Form 4 filings · as of 2026-02-12